LVS · NYSE
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $13.02B | $11.30B | $10.37B | $4.11B | $4.23B | $2.94B | $12.13B | $13.73B |
| Research & Development | $269.00M | $228.00M | $205.00M | $143.00M | $109.00M | — | — | — |
| Selling, General & Administrative | $1.19B | $1.15B | $1.11B | $936.00M | $831.00M | $798.00M | $1.12B | $1.48B |
| Operating Expenses | $10.20B | $8.90B | $8.06B | $4.90B | $4.92B | $4.33B | $8.76B | $9.98B |
| Operating Income | $2.82B | $2.40B | $2.31B | -$792.00M | -$689.00M | -$1.39B | $3.37B | $3.75B |
| Interest Expense | $746.00M | $727.00M | $818.00M | $702.00M | $621.00M | $523.00M | $449.00M | $446.00M |
| Other Income / (Expense) | -$15.00M | $10.00M | -$8.00M | -$9.00M | -$31.00M | $19.00M | $56.00M | $26.00M |
| Income Before Taxes | $2.21B | $1.96B | $1.77B | -$1.39B | -$1.47B | -$1.88B | $3.60B | $3.33B |
| Provision for Income Taxes | $347.00M | $208.00M | $344.00M | $154.00M | -$5.00M | $24.00M | $432.00M | $375.00M |
| Net Income | $1.63B | $1.45B | $1.22B | $1.83B | -$961.00M | -$1.69B | $2.70B | $2.41B |
| Basic EPS | $2.35 | $1.97 | $1.60 | $2.40 | -$1.26 | -$2.21 | $3.50 | $3.07 |
| Diluted EPS | $2.35 | $1.96 | $1.60 | $2.40 | -$1.26 | -$2.21 | $3.50 | $3.07 |
| Basic Shares Outstanding | 691.00M | 735.00M | 763.00M | 764.00M | 764.00M | 764.00M | 771.00M | 786.00M |
| Diluted Shares Outstanding | 693.00M | 737.00M | 765.00M | 764.00M | 764.00M | 764.00M | 771.00M | 786.00M |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Dec 2026 | $3.12 | $2.93 | $3.34 | 9 | ↑0 ↓8 |
| Dec 2027 | $3.48 | $3.26 | $3.66 | 9 | ↑0 ↓8 |
| Dec 2028 | $3.75 | $3.26 | $4.26 | 5 | ↑0 ↓0 |
| Dec 2029 | $4.77 | $4.77 | $4.77 | 1 | ↑0 ↓0 |